Karen E Joynt Maddox
Karen E Joynt Maddox
Response by Gentile et al to Letters Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults" [0.03%]
关于Gentile等人的信的回复：“成人冠状动脉异常起源的临床和预后意义”文章的来信答复
Francesco Gentile,Michele Emdin,Alberto Clemente
Francesco Gentile
Letter by Han et al Regarding Article, "Clinical and Prognostic Significance of Anomalous Origin of a Coronary Artery in Adults" [0.03%]
韩等人关于文章“成人冠状动脉异常起源的临床和预后意义”的信件
Q Joyce Han,Ada C Stefanescu Schmidt,Doreen DeFaria Yeh
Q Joyce Han
Gabriel Steg
Gabriel Steg
Prognosis of Recurrent Venous Thromboembolism During Extended Apixaban Therapy for Cancer-Associated Thrombosis: Insights From the API-CAT Randomized Trial [0.03%]
阿哌沙班治疗癌症相关血栓病延长疗效对复发性静脉血栓栓塞的预后：来自API-CAT随机试验的见解
Isabelle Mahé,Céline Chapelle,Marc Righini et al.
Isabelle Mahé et al.
Scaled Multidimensional Assays of Variant Effect Identify Sequence-Function Relationships in Hypertrophic Cardiomyopathy [0.03%]
缩放的多维变异效应测定可以识别肥厚型心肌病中的序列功能关系
Yuta Yamamoto,Kaiser Chua,David Staudt et al.
Yuta Yamamoto et al.
Background: An estimated 1 in 500 people lives with hypertrophic cardiomyopathy (HCM), a disease for which genetic diagnosis can identify family members at risk and increasingly guide therapy. Variants in the MYBPC3 gene,...
Exercise Training in High-Risk Populations: A Scientific Statement From the American Heart Association [0.03%]
高危人群锻炼培训：美国心脏协会科学声明
Jerome L Fleg,Jessica R Golbus,Jonathan Afilalo et al.
Jerome L Fleg et al.
There is broad consensus on the benefits of aerobic exercise training in patients with cardiovascular disease to improve cardiorespiratory fitness and lower the risk of adverse cardiovascular events. However, certain high-risk populations s...
Cardiovascular Health Equity: Time for a New Era of Science, Sociology, and Interventions [0.03%]
心血管健康公平性：科学、社会学和干预措施的新时代的到来
Dipti Itchhaporia,Clyde W Yancy,Stacey E Rosen et al.
Dipti Itchhaporia et al.
Editorial
Circulation. 2026 Jul 8. DOI:10.1161/CIR.0000000000001445 2026
Deprescribing in Patients With Cardiovascular Disease Experiencing Polypharmacy: A Scientific Statement From the American Heart Association [0.03%]
美国心脏协会关于心血管疾病多药治疗患者的减药的科学声明
Robert J DiDomenico,Joel C Marrs,Adam P Bress et al.
Robert J DiDomenico et al.
Polypharmacy in patients with cardiovascular disease occurs frequently across the age spectrum and can lead to inappropriate prescribing and adverse outcomes. Despite polypharmacy being a known problem for decades, there is limited guidance...